NO2499238T3 - - Google Patents
Info
- Publication number
- NO2499238T3 NO2499238T3 NO10830580A NO10830580A NO2499238T3 NO 2499238 T3 NO2499238 T3 NO 2499238T3 NO 10830580 A NO10830580 A NO 10830580A NO 10830580 A NO10830580 A NO 10830580A NO 2499238 T3 NO2499238 T3 NO 2499238T3
- Authority
- NO
- Norway
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0622—Glial cells, e.g. astrocytes, oligodendrocytes; Schwann cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/30—Nerves; Brain; Eyes; Corneal cells; Cerebrospinal fluid; Neuronal stem cells; Neuronal precursor cells; Glial cells; Oligodendrocytes; Schwann cells; Astroglia; Astrocytes; Choroid plexus; Spinal cord tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0081—Purging biological preparations of unwanted cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56966—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26044109P | 2009-11-12 | 2009-11-12 | |
US32679910P | 2010-04-22 | 2010-04-22 | |
PCT/US2010/055956 WO2011059952A1 (en) | 2009-11-12 | 2010-11-09 | Methods and compositions for expanding, identifying, characterizing and enhancing potency of mammalian-derived glial restricted progenitor cells |
Publications (1)
Publication Number | Publication Date |
---|---|
NO2499238T3 true NO2499238T3 (no) | 2018-01-27 |
Family
ID=43991980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO10830580A NO2499238T3 (no) | 2009-11-12 | 2010-11-09 |
Country Status (12)
Country | Link |
---|---|
US (2) | US10351823B2 (no) |
EP (2) | EP3269803A3 (no) |
JP (2) | JP5952737B2 (no) |
CN (2) | CN102686721B (no) |
AU (1) | AU2010319680B2 (no) |
CA (1) | CA2780541C (no) |
DK (1) | DK2499238T3 (no) |
ES (1) | ES2649396T3 (no) |
HK (1) | HK1174953A1 (no) |
NO (1) | NO2499238T3 (no) |
PL (1) | PL2499238T3 (no) |
WO (1) | WO2011059952A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1480521B1 (en) | 2002-02-15 | 2015-02-25 | Cornell Research Foundation, Inc. | Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
EP2283116B1 (en) | 2008-05-08 | 2016-09-28 | University Of Rochester | Treating myelin diseases with optimized cell preparations |
US10450546B2 (en) | 2013-02-06 | 2019-10-22 | University Of Rochester | Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of myelin disorders |
CN107001995A (zh) * | 2014-09-26 | 2017-08-01 | 宝洁公司 | 包含恶臭减少组合物的清洁和/或处理组合物 |
US9724432B2 (en) | 2015-04-30 | 2017-08-08 | University Of Rochester | Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder |
US11690876B2 (en) | 2017-05-10 | 2023-07-04 | University Of Rochester | Methods of treating neuropsychiatric disorders |
CN108624560B (zh) * | 2018-06-01 | 2022-04-08 | 南京艾尔普再生医学科技有限公司 | 一种分化培养基及少突胶质前体细胞的制备方法 |
US10995325B2 (en) | 2019-03-21 | 2021-05-04 | Fornia Biosolutions, Inc. | Additional phytase variants and methods |
WO2023278783A1 (en) * | 2021-06-30 | 2023-01-05 | The Regents Of The University Of California | Methods to generate glial restricted neural progenitor cells and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6235527B1 (en) * | 1997-11-29 | 2001-05-22 | University Of Utah Research Foundation | Lineage restricted glial precursors from the central nervous system |
CA2295197A1 (en) | 1999-09-08 | 2001-03-08 | Appleton Papers Inc. | Thermally-responsive record material |
US6878543B1 (en) * | 1999-10-25 | 2005-04-12 | Nsgene Sa | Cultures of GFAP+ nestin+ cells that differentiate to neurons |
AR046076A1 (es) * | 2003-07-18 | 2005-11-23 | Otsuka Pharma Co Ltd | Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida |
US20050272149A1 (en) * | 2004-06-02 | 2005-12-08 | Life & Brain Gmbh | Therapeutic delivery of adenosine into a tissue |
US20090155223A1 (en) * | 2007-08-14 | 2009-06-18 | The Johns Hopkins University | Cell-based compositions and methods for treating conditions of the nervous system |
-
2010
- 2010-11-09 EP EP17188092.5A patent/EP3269803A3/en not_active Withdrawn
- 2010-11-09 PL PL10830580T patent/PL2499238T3/pl unknown
- 2010-11-09 CA CA2780541A patent/CA2780541C/en active Active
- 2010-11-09 US US13/508,803 patent/US10351823B2/en active Active
- 2010-11-09 NO NO10830580A patent/NO2499238T3/no unknown
- 2010-11-09 CN CN201080051269.2A patent/CN102686721B/zh active Active
- 2010-11-09 JP JP2012538881A patent/JP5952737B2/ja active Active
- 2010-11-09 EP EP10830580.6A patent/EP2499238B1/en active Active
- 2010-11-09 DK DK10830580.6T patent/DK2499238T3/en active
- 2010-11-09 ES ES10830580.6T patent/ES2649396T3/es active Active
- 2010-11-09 CN CN201610055313.6A patent/CN105602889A/zh active Pending
- 2010-11-09 WO PCT/US2010/055956 patent/WO2011059952A1/en active Application Filing
- 2010-11-09 AU AU2010319680A patent/AU2010319680B2/en active Active
-
2013
- 2013-02-22 HK HK13102272.0A patent/HK1174953A1/zh unknown
-
2016
- 2016-02-15 JP JP2016026441A patent/JP6346629B2/ja active Active
-
2018
- 2018-09-19 US US16/135,626 patent/US20190032010A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL2499238T3 (pl) | 2018-04-30 |
CN102686721A (zh) | 2012-09-19 |
AU2010319680A1 (en) | 2012-07-05 |
HK1174953A1 (zh) | 2013-06-21 |
EP2499238A4 (en) | 2013-10-02 |
DK2499238T3 (en) | 2017-12-04 |
CA2780541C (en) | 2015-07-14 |
US20190032010A1 (en) | 2019-01-31 |
CN105602889A (zh) | 2016-05-25 |
US20120230963A1 (en) | 2012-09-13 |
WO2011059952A1 (en) | 2011-05-19 |
EP3269803A2 (en) | 2018-01-17 |
US10351823B2 (en) | 2019-07-16 |
JP2016146831A (ja) | 2016-08-18 |
AU2010319680B2 (en) | 2014-05-29 |
EP2499238A1 (en) | 2012-09-19 |
JP2013510570A (ja) | 2013-03-28 |
ES2649396T3 (es) | 2018-01-11 |
EP2499238B1 (en) | 2017-08-30 |
EP3269803A3 (en) | 2018-04-25 |
CA2780541A1 (en) | 2011-05-19 |
CN102686721B (zh) | 2016-02-10 |
JP6346629B2 (ja) | 2018-06-20 |
JP5952737B2 (ja) | 2016-07-13 |